CRIS Current Research Information System

PICCINNI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.491
EU - Europa 3.196
AS - Asia 1.386
AF - Africa 196
SA - Sud America 20
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.295
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.471
IT - Italia 898
GB - Regno Unito 786
CN - Cina 518
DE - Germania 416
SE - Svezia 322
SG - Singapore 306
VN - Vietnam 301
RU - Federazione Russa 173
IN - India 159
UA - Ucraina 145
FR - Francia 128
IE - Irlanda 110
ZA - Sudafrica 74
CI - Costa d'Avorio 58
EE - Estonia 56
NL - Olanda 52
TG - Togo 42
BE - Belgio 30
FI - Finlandia 21
JO - Giordania 20
CA - Canada 18
JP - Giappone 16
TW - Taiwan 15
CH - Svizzera 13
NG - Nigeria 13
HK - Hong Kong 10
HR - Croazia 9
AT - Austria 6
GR - Grecia 6
ID - Indonesia 6
LB - Libano 6
SA - Arabia Saudita 6
SC - Seychelles 6
CO - Colombia 5
PL - Polonia 5
AU - Australia 4
BG - Bulgaria 4
BR - Brasile 4
CZ - Repubblica Ceca 4
LT - Lituania 4
SY - Repubblica araba siriana 4
UZ - Uzbekistan 4
AR - Argentina 3
CL - Cile 3
ES - Italia 3
IR - Iran 3
TH - Thailandia 3
DK - Danimarca 2
MX - Messico 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
KZ - Kazakistan 1
MV - Maldive 1
MY - Malesia 1
NP - Nepal 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
VE - Venezuela 1
Totale 8.295
Salva come PNG Salva come JPEG
Città #
Southend 701
Chandler 361
Fairfield 338
Santa Clara 309
Singapore 253
Ashburn 235
Dong Ket 199
Wilmington 197
Princeton 193
Ann Arbor 150
Woodbridge 147
Houston 140
Seattle 114
Dublin 105
Cambridge 98
Jacksonville 86
Bologna 85
Boardman 82
Westminster 78
Nanjing 76
Padova 75
Abidjan 58
Rome 56
Medford 48
Shenyang 43
Lomé 42
Saint Petersburg 39
Milan 37
Berlin 34
Bremen 34
Dearborn 34
Mülheim 33
Beijing 30
Brussels 28
Nanchang 27
Redwood City 26
Jinan 25
Changsha 23
Olalla 23
San Diego 23
Hebei 21
Helsinki 21
San Venanzo 21
Amman 20
Frankfurt am Main 17
Palermo 16
Tianjin 16
Falls Church 15
Los Angeles 15
Turin 15
Florence 14
Guangzhou 14
Haikou 14
Hangzhou 14
Shanghai 14
Abeokuta 13
Taipei 13
Zhengzhou 13
Norwalk 12
Biella 11
Jiaxing 11
Kunming 11
Ningbo 11
Yubileyny 11
Bari 10
Lanzhou 10
Messina 10
New York 10
Phoenix 10
London 9
Redmond 9
Torino 9
Toronto 9
Bühl 8
Ferrero 8
Fuzhou 8
Portsmouth 8
Bern 7
Cesena 7
Düsseldorf 7
Montesilvano Marina 7
Caserta 6
Frankfurt Am Main 6
Ottawa 6
Parma 6
Pescara 6
Venice 6
Wiesbaden 6
Argenta 5
Chicago 5
Groningen 5
Mahé 5
Mountain View 5
Napoli 5
Plauen 5
Riyadh 5
Siena 5
Taiyuan 5
Taizhou 5
Verona 5
Totale 5.286
Salva come PNG Salva come JPEG
Nome #
Leucoencefalopatia Multifocale Progressiva: complicanza dell'immunosoppressione o reazione avversa da farmaci? 472
Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS) 254
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 197
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies 196
Farmacoutilizzazione in ospedale: analisi delle variabilità in una realtà regionale 173
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 158
Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health 157
Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting 142
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 141
Clinically important drug-drug interactions in poly-treated elderly outpatients: A campaign to improve appropriateness in general practice 141
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database. 140
Association between Paraesthesia and Local Anesthetics: Data Mining of the Public Version of the FDA Adverse Event Reporting System, 140
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. 136
Social and clinical descriptors of antipsychotic prescription 134
La condivisione dei trattamenti farmacologici in psichiatria e la percezione degli effetti avversi ai farmaci antipisicotici da medico, paziente e familiare 132
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants 131
Triptans and serious adverse vascular events: Data mining of the FDA Adverse Event Reporting System database 127
A real-world study on unmet medical needs in triptan-treated migraine: Prevalence, preventive therapies and triptan use modification from a large Italian population along two years 125
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey 123
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 120
Aderenza al trattamento con Bifosfonati: studio di coorte retrospettivo su database amministrativi dell’Emilia Romagna 116
Paraesthesia after Local Anaesthetics: An Analysis of Reports to the FDA Adverse Event Reporting System 116
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database. 115
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective 112
Predictors of non-adherence with oral bisphosphonates: an Italian retrospective cohort study on administrative databases 111
A project for monitoring disease modifying drug prescriptions for multiple sclerosis in Emilia Romagna 107
Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region 102
Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases 102
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures 101
Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden. 101
Aderenza alla terapia antidepressiva in Emilia-Romagna 101
Prescription patterns of antiepileptic drugs in young women: development of a tool to distinguish between epilepsy and psychiatric disorders 101
Prescription patterns of oral bisphosphonates in Italian patients with osteoporosis 100
Determinanti demografici, clinici ed organizzativi dell’aderenza alla poli-terapia dopo infarto miocardico acuto 100
Determinanti demografici, clinici ed organizzativi dell'aderenza alla poli-terapia dopo infarto miocardico acuto 99
Profili di utilizzo dei farmaci antipsicotici nei centri salute mentale della AUSL di Bologna: determinanti clinici e sociali 97
Natalizumab: a country-based surveillance program 97
Risk-management of natalizumab: a drug utilization study on duration of therapy and cause of discontinuation in Emilia-Romagna region 97
Infarto del miocardio, edema maculare e fratture associate ai glitazoni: analisi del database di segnalazione spontanea FDA_AERS 96
Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence 96
Impact of notoriety bias on reporting of pancreatitis with antidiabetics: the case of exenatide 95
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to Bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures, 94
Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study 94
Pioglitazone-associated bladder cancer: the contribution of spontaneous reporting analysis on the basis of FDA_AERS database 93
Safety profile of thiazolidinediones on the basis of the FDA-AERS database: cardiovascular and bone fracture risks for rosiglitazone and pioglitazone 93
Burden of community-acquired pneumonia in Italian general practice 93
Progetto europeo di confronto dell'uso dei farmaci 92
Three years of experience: the Italian registry and safety data update 92
Predictors of antipsychotic prescription in a Northern Italian District (Bologna) 92
Fattori determinanti nell'utilizzo dei farmaci antipsicotici 91
The pharmacovigilance program on natalizumab in Italy: 2 years of experience 90
Progressive Multifocal Leukoencephalopathy: an effect of immunodeficiency or an adverse drug reaction? 89
Glucagon-like peptide 1-based drugs and pancreatic safety. 88
Organisational determinants of adherence to secondary prevention medications after acute myocardial infarction 87
Triptans and serious cardiovascular events: possible safety signals from the FDA Adverse Event Reporting System database 86
Use and Perception of Phytoestrogens in Postmenopausal Women: Result of a Questionnaire-Based Survey 85
Progetto di monitoraggio della prescrizione di farmaci disease-modifying nella sclerosi multipla in Emilia-Romagna 85
La rimborsabilità di memantina - il trilemma di Münchausen 84
L’uso dei farmaci in Italia. Rapporto nazionale anno 2011 80
Drug-induced Progressive Multifocal Leukoencephalopathy: data mining of international spontaneous ADR report databases 79
Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database. 79
The key role of patient in the antipsychotic therapy: shared decision making, adherence and research 79
Psychiatrists’ Use of Shared Decision Making in the Treatment of Psychosis: The “Farmaci and Famiglie” Project in Bologna 77
The Italian Surveillance Program on Natalizumab 76
Progressive Multifocal Leukoencephalopathy (PML): only immunosuppressive complication or also drug adverse reaction? 75
Monitoring disease-modifying drugs in multiple sclerosis in Emilia Romagna 73
The Italian Natalizumab Registry: a 1-year follow-up 69
Lack of adherence to oral bisphosphonates in Italian patients: prevalence and predictors 69
Prescrizione di Entacapone nella Regione Emilia-Romagna 69
Interrupted time series analysis on the impact of dronedarone authorisation on Italian and Swedish antiarrhythmic prescriptions 69
I rapporti tra medici, pazienti e familiari nella scelta delle terapie farmacologiche dei disturbi psichici: un’indagine presso il dipartimento di salute mentale della AUSL di Bologna 68
VII Report Health Search Anno 2011/2012 66
Factors Influencing the Disproportional Association Between Triptans and Cerebrovascular Events Within the FDA_AERS Database: Causal Association or Reporting Bias? 64
Monitoring the use of disease-modifying drugs in multiple sclerosis 64
Drug-related Progressive Multifocal Leukoencephalopathy (PML): datamining of FDA_AERS (Adverse Event Reporting System) 63
Insights into real-world treatment of cluster headache through a large Italian database: prevalence, prescription patterns, and costs 57
Use of disease-modifying drugs for multiple sclerosis in neurological centres of Emilia Romagna 56
Drug utilisation of antidepressants in Generai Practice: choice of drugs and adherence in an Italian region 54
Impact of dronedarone authorisation on antiarrhythmic utilisation: interrupted time series strategy on Italian and Swedish prescription databases 51
Totale 8.466
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.538
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020140 0 0 0 0 0 0 0 0 0 0 45 95
2020/20211.044 240 51 19 58 32 56 30 45 54 47 58 354
2021/20221.466 153 66 69 105 127 93 28 87 45 98 356 239
2022/20231.598 195 199 116 212 88 116 40 108 261 64 142 57
2023/2024563 44 79 38 70 57 50 38 31 25 46 58 27
2024/20251.343 99 239 110 116 421 107 86 48 21 74 22 0
Totale 8.466